Latest news

The two Chrysanthemum cinerariaefolium extracts opposite are currently making their way through the review programme under the Biocidal Products Regulation (EU) No 528/2012. The EU Biocidal Product Committee completed its review in September 2021...
Companies need to understand that biostimulants are still an evolving regulatory area in the US. This means claims that are allowed in other countries may prove to be problematic for companies looking to register a product in the states...
In this insight piece we look at how to lay the groundwork for a smoother authorisation experience in the European Union (EU) and Great Britain (GB) under their separate BPR regimes. The regulatory landscape for biocidal products has changed...
Haven't found what you were looking for?

Servicesarrow pointing right

We help companies navigate the regulatory landscape across a range of geographies and jurisdictions. Read about the comprehensive range of services we offer.

Professionalsarrow pointing right

Our regulatory specialists and scientists address all aspects of product registration and ongoing compliance. Read more about the individuals who make up our multi-disciplinary teams.

Contact us